Compare $IRWD vs $SGMT | Chartloom

Compare

$IRWD vs $SGMT

Ironwood Pharmaceuticals Inc · Sagimet Biosciences Inc

IRWD

Ironwood Pharmaceuticals Inc

SGMT

Sagimet Biosciences Inc

Compare $IRWD vs $SGMT

Comparing Ironwood Pharmaceuticals Inc and Sagimet Biosciences Inc

IRWDIronwood Pharmaceuticals Inc

SGMTSagimet Biosciences Inc

IRWDIronwood Pharmaceuticals Inc

Market cap

$629M

P/E (TTM)

4.92x

Forward P/E (NTM)

2.96x

Forward P/S (NTM)

1.30x

Rev growth (TTM)

26.2%

YTD performance

-10.5%

52W performance

141.8%

FCF yield

29.5%

SGMTSagimet Biosciences Inc

Market cap

$551M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

194.48x

Rev growth (TTM)

—

YTD performance

49.1%

52W performance

22.2%

FCF yield

-7.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IRWD

SGMT

Detailed metrics comparison

IRWD

Ironwood Pharmaceuticals Inc

SGMT

Sagimet Biosciences Inc

Market Cap

IRWD$629M

SGMT$551M

Enterprise Value

IRWD$935M

SGMT$386M

Price

IRWD$3.82

SGMT$8.93

P/E Ratio

IRWD4.92x

SGMTN/A

P/S Ratio

IRWD1.62x

SGMT0.00x

EV/Sales

IRWD2.40x

SGMT0.00x

EV/EBITDA

IRWD3.93x

SGMT0.00x

P/B Ratio

IRWD0.85x

SGMT2.20x

P/FCF Ratio

IRWD3.39x

SGMTN/A

EV/FCF

IRWD5.04x

SGMT-9.24x

PEG Ratio

IRWDN/A

SGMTN/A

Forward P/E (NTM)

IRWD2.96x

SGMTN/A

Forward P/S (NTM)

IRWD1.30x

SGMT194.48x

Revenue (TTM)

IRWD$389M

SGMT$0

Revenue Growth (YoY)

IRWD26.2%

SGMTN/A

Forward Rev Growth

IRWD6.4%

SGMT89.0%

Gross Margin (TTM)

IRWD100.0%

SGMT0.0%

Operating Margin (TTM)

IRWD60.2%

SGMT0.0%

EBITDA Margin (TTM)

IRWD61.1%

SGMT0.0%

Net Margin (TTM)

IRWD33.4%

SGMT0.0%

FCF Margin (TTM)

IRWD47.7%

SGMTN/A

Net Income (TTM)

IRWD$130M

SGMT$-47M

FCF (TTM)

IRWD$186M

SGMT$-42M

EPS (TTM)

IRWD$0.78

SGMT-$0.89

ROE (TTM)

IRWD29.3%

SGMT-3196.0%

ROA (TTM)

IRWD34.3%

SGMT-3057.0%

ROIC (TTM)

IRWD17.9%

SGMT-3196.0%

Cash

IRWD$79M

SGMT$166M

Debt

IRWD$385M

SGMT$0

Net Cash/Debt

IRWD$-306M

SGMT$166M

Current Ratio (TTM)

IRWD6.06x

SGMT45.02x

Quick Ratio (TTM)

IRWD5.84x

SGMT44.43x

Debt/Equity (TTM)

IRWD0.56x

SGMT0.00x

Debt/Assets (TTM)

IRWD0.0%

SGMT0.0%

Interest Coverage (TTM)

IRWDN/A

SGMTN/A

Net Debt/EBITDA (TTM)

IRWD0.00x

SGMT0.00x

Beta

IRWD0.22

SGMT3.54

52W Performance

IRWD141.8%

SGMT22.2%

YTD Performance

IRWD-10.5%

SGMT49.1%

% from 52W High

IRWD-33.9%

SGMT-22.0%

% from 52W Low

IRWD170.9%

SGMT98.4%

Asset Turnover (TTM)

IRWD1.03x

SGMT0.00x

FCF Yield (TTM)

IRWD29.5%

SGMT-7.6%

Earnings Yield (TTM)

IRWD20.7%

SGMT-8.5%

Dividend Yield (TTM)

IRWDN/A

SGMTN/A

Rule of 40

IRWD73.8

SGMT0.0

EV/GP/RG

IRWD0.10

SGMTN/A

Ticker research

View IRWD research View SGMT research

Metric	IRWD Ironwood Pharmaceuticals Inc	SGMT Sagimet Biosciences Inc
Market & Valuation
Market Cap	$629M	$551M
Enterprise Value	$935M	$386M
Price	$3.82	$8.93
P/E Ratio	4.92x	N/A
P/S Ratio	1.62x	0.00x
EV/Sales	2.40x	0.00x
EV/EBITDA	3.93x	0.00x
P/B Ratio	0.85x	2.20x
P/FCF Ratio	3.39x	N/A
EV/FCF	5.04x	-9.24x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	2.96x	N/A
Forward P/S (NTM)	1.30x	194.48x
Revenue & Growth
Revenue (TTM)	$389M	$0
Revenue Growth (YoY)	26.2%	N/A
Forward Rev Growth	6.4%	89.0%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	60.2%	0.0%
EBITDA Margin (TTM)	61.1%	0.0%
Net Margin (TTM)	33.4%	0.0%
FCF Margin (TTM)	47.7%	N/A
Net Income (TTM)	$130M	$-47M
FCF (TTM)	$186M	$-42M
EPS (TTM)	$0.78	-$0.89
ROE (TTM)	29.3%	-3196.0%
ROA (TTM)	34.3%	-3057.0%
ROIC (TTM)	17.9%	-3196.0%
Financial Health
Cash	$79M	$166M
Debt	$385M	$0
Net Cash/Debt	$-306M	$166M
Current Ratio (TTM)	6.06x	45.02x
Quick Ratio (TTM)	5.84x	44.43x
Debt/Equity (TTM)	0.56x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.22	3.54
52W Performance	141.8%	22.2%
YTD Performance	-10.5%	49.1%
% from 52W High	-33.9%	-22.0%
% from 52W Low	170.9%	98.4%
Efficiency & Yields
Asset Turnover (TTM)	1.03x	0.00x
FCF Yield (TTM)	29.5%	-7.6%
Earnings Yield (TTM)	20.7%	-8.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	73.8	0.0
EV/GP/RG	0.10	N/A
Ticker research	View IRWD research	View SGMT research

Valuation

P/E Ratio

IRWD

4.92x

P/S Ratio

SGMT

0.00x

IRWD

1.62x

EV/FCF

SGMT

-9.24x

IRWD

5.04x

Growth & revenue

Revenue Growth TTM

IRWD

26.2%

Forward Revenue Growth

SGMT

89.0%

IRWD

6.4%

Profitability & performance

Gross Margin

IRWD

100.0%

SGMT

0.0%

ROE

IRWD

29.3%

SGMT

-3196.0%

FCF Yield %

IRWD

29.5%

SGMT

-7.6%

52-Week Performance

IRWD

141.8%

SGMT

22.2%

Detailed metrics comparison

IRWD

Ironwood Pharmaceuticals Inc

SGMT

Sagimet Biosciences Inc

Market Cap

IRWD$629M

SGMT$551M

Enterprise Value

IRWD$935M

SGMT$386M

Price

IRWD$3.82

SGMT$8.93

P/E Ratio

IRWD4.92x

SGMTN/A

P/S Ratio

IRWD1.62x

SGMT0.00x

EV/Sales

IRWD2.40x

SGMT0.00x

EV/EBITDA

IRWD3.93x

SGMT0.00x

P/B Ratio

IRWD0.85x

SGMT2.20x

P/FCF Ratio

IRWD3.39x

SGMTN/A

EV/FCF

IRWD5.04x

SGMT-9.24x

PEG Ratio

IRWDN/A

SGMTN/A

Forward P/E (NTM)

IRWD2.96x

SGMTN/A

Forward P/S (NTM)

IRWD1.30x

SGMT194.48x

Revenue (TTM)

IRWD$389M

SGMT$0

Revenue Growth (YoY)

IRWD26.2%

SGMTN/A

Forward Rev Growth

IRWD6.4%

SGMT89.0%

Gross Margin (TTM)

IRWD100.0%

SGMT0.0%

Operating Margin (TTM)

IRWD60.2%

SGMT0.0%

EBITDA Margin (TTM)

IRWD61.1%

SGMT0.0%

Net Margin (TTM)

IRWD33.4%

SGMT0.0%

FCF Margin (TTM)

IRWD47.7%

SGMTN/A

Net Income (TTM)

IRWD$130M

SGMT$-47M

FCF (TTM)

IRWD$186M

SGMT$-42M

EPS (TTM)

IRWD$0.78

SGMT-$0.89

ROE (TTM)

IRWD29.3%

SGMT-3196.0%

ROA (TTM)

IRWD34.3%

SGMT-3057.0%

ROIC (TTM)

IRWD17.9%

SGMT-3196.0%

Cash

IRWD$79M

SGMT$166M

Debt

IRWD$385M

SGMT$0

Net Cash/Debt

IRWD$-306M

SGMT$166M

Current Ratio (TTM)

IRWD6.06x

SGMT45.02x

Quick Ratio (TTM)

IRWD5.84x

SGMT44.43x

Debt/Equity (TTM)

IRWD0.56x

SGMT0.00x

Debt/Assets (TTM)

IRWD0.0%

SGMT0.0%

Interest Coverage (TTM)

IRWDN/A

SGMTN/A

Net Debt/EBITDA (TTM)

IRWD0.00x

SGMT0.00x

Beta

IRWD0.22

SGMT3.54

52W Performance

IRWD141.8%

SGMT22.2%

YTD Performance

IRWD-10.5%

SGMT49.1%

% from 52W High

IRWD-33.9%

SGMT-22.0%

% from 52W Low

IRWD170.9%

SGMT98.4%

Asset Turnover (TTM)

IRWD1.03x

SGMT0.00x

FCF Yield (TTM)

IRWD29.5%

SGMT-7.6%

Earnings Yield (TTM)

IRWD20.7%

SGMT-8.5%

Dividend Yield (TTM)

IRWDN/A

SGMTN/A

Rule of 40

IRWD73.8

SGMT0.0

EV/GP/RG

IRWD0.10

SGMTN/A

Ticker research

View IRWD research View SGMT research

Metric	IRWD Ironwood Pharmaceuticals Inc	SGMT Sagimet Biosciences Inc
Market & Valuation
Market Cap	$629M	$551M
Enterprise Value	$935M	$386M
Price	$3.82	$8.93
P/E Ratio	4.92x	N/A
P/S Ratio	1.62x	0.00x
EV/Sales	2.40x	0.00x
EV/EBITDA	3.93x	0.00x
P/B Ratio	0.85x	2.20x
P/FCF Ratio	3.39x	N/A
EV/FCF	5.04x	-9.24x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	2.96x	N/A
Forward P/S (NTM)	1.30x	194.48x
Revenue & Growth
Revenue (TTM)	$389M	$0
Revenue Growth (YoY)	26.2%	N/A
Forward Rev Growth	6.4%	89.0%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	60.2%	0.0%
EBITDA Margin (TTM)	61.1%	0.0%
Net Margin (TTM)	33.4%	0.0%
FCF Margin (TTM)	47.7%	N/A
Net Income (TTM)	$130M	$-47M
FCF (TTM)	$186M	$-42M
EPS (TTM)	$0.78	-$0.89
ROE (TTM)	29.3%	-3196.0%
ROA (TTM)	34.3%	-3057.0%
ROIC (TTM)	17.9%	-3196.0%
Financial Health
Cash	$79M	$166M
Debt	$385M	$0
Net Cash/Debt	$-306M	$166M
Current Ratio (TTM)	6.06x	45.02x
Quick Ratio (TTM)	5.84x	44.43x
Debt/Equity (TTM)	0.56x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.22	3.54
52W Performance	141.8%	22.2%
YTD Performance	-10.5%	49.1%
% from 52W High	-33.9%	-22.0%
% from 52W Low	170.9%	98.4%
Efficiency & Yields
Asset Turnover (TTM)	1.03x	0.00x
FCF Yield (TTM)	29.5%	-7.6%
Earnings Yield (TTM)	20.7%	-8.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	73.8	0.0
EV/GP/RG	0.10	N/A
Ticker research	View IRWD research	View SGMT research